Monocyte Chemoattractant Protein-1 Induces a Novel Transcription Factor That Causes Cardiac Myocyte Apoptosis and Ventricular Dysfunction

Monocyte chemoattractant protein-1 (MCP-1; CCL2)–mediated inflammation plays a critical role in the development of ischemic heart disease (IHD). However, the gene expression changes caused by signal transduction, triggered by MCP-1 binding to its receptor CCR2, and their possible role in the development of IHD are not understood. We present evidence that MCP-1 binding to CCR2 induces a novel transcription factor (MCP-induced protein [MCPIP]) that causes cell death. Gene microarray analysis showed that when expressed in hiuman embryonic kidney 293 cells, MCPIP induced apoptotic gene families before causing cell death. Mutagenesis studies showed that the structural features required for transcription factor–like activity were also required for causing cell death. Activation of caspase-3 was detected after MCPIP transfection and Z-VAD-fmk partially inhibited cell death. Cardiomyocyte-targeted expression of MCP-1 in mice caused death by heart failure at 6 months of age. MCPIP expression increased in parallel with the development of ventricular dysfunction. In situ hybridization showed the presence of MCPIP transcripts in the cardiomyocytes and immunohistochemistry showed that MCPIP was associated with the cardiomyocyte nuclei of apoptotic cardiomyocytes. CCR2 expression in cardiomyocytes increased with the development of IHD. MCPIP production induced by MCP-1 binding to CCR2 in the cardiomyocytes is probably involved in the development of IHD in this murine model. MCPIP transcript levels were much higher in the explanted human hearts with IHD than with nonischemic heart disease. These results provide a molecular insight into how chronic inflammation and exposure to MCP-1 contributes to heart failure and suggest that MCPIP could be a potential target for therapeutic intervention.

[1]  The Metabolic Syndrome , 2003 .

[2]  E. Duhig,et al.  Images in cardiovascular medicine. Echocardiographic description of recurrent idiopathic giant-cell myocarditis in cardiac allograft. , 2003, Circulation.

[3]  P. Libby,et al.  Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. , 1998, Molecular cell.

[4]  K. Woollard,et al.  Direct modulatory effect of C‐reactive protein on primary human monocyte adhesion to human endothelial cells , 2002, Clinical and experimental immunology.

[5]  G. Christensen,et al.  Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure. , 2000, Cardiovascular research.

[6]  T. Kawano,et al.  Monocyte Chemotactic Protein-1 Receptor CCR2B Is a Glycoprotein That Has Tyrosine Sulfation in a Conserved Extracellular N-Terminal Region , 2000, The Journal of Immunology.

[7]  X. Busquets,et al.  IFN-γ prevents TNF-α-induced apoptosis in C2C12 myotubes through down-regulation of TNF-R2 and increased NF-κB activity , 2005 .

[8]  A. Takeshita,et al.  Importance of Monocyte Chemoattractant Protein-1 Pathway in Neointimal Hyperplasia After Periarterial Injury in Mice and Monkeys , 2002, Circulation research.

[9]  I. Porto,et al.  Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies , 2002, Heart.

[10]  Tsonwin Hai,et al.  Characterization of Human Activating Transcription Factor 4, a Transcriptional Activator That Interacts with Multiple Domains of cAMP-responsive Element-binding Protein (CREB)-binding Protein (CBP)* , 1997, The Journal of Biological Chemistry.

[11]  Yigong Shi,et al.  Structure of the apoptotic protease-activating factor 1 bound to ADP , 2005, Nature.

[12]  P. Kolattukudy,et al.  Monocyte chemotactic protein 1 upregulates IL-1beta expression in human monocytes. , 2000, Biochemical and biophysical research communications.

[13]  Tomonori Kawano,et al.  Site-directed mutagenesis of CCR2 identified amino acid residues in transmembrane helices 1, 2, and 7 important for MCP-1 binding and biological functions. , 2005, Biochemical and biophysical research communications.

[14]  M. Entman,et al.  Chemokines in myocardial ischemia. , 2005, Trends in cardiovascular medicine.

[15]  John Calvin Reed,et al.  BNIP3 Heterodimerizes with Bcl-2/Bcl-XL and Induces Cell Death Independent of a Bcl-2 Homology 3 (BH3) Domain at Both Mitochondrial and Nonmitochondrial Sites* , 2000, The Journal of Biological Chemistry.

[16]  C. Orosz,et al.  Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle. , 1998, The American journal of pathology.

[17]  W. Koenig,et al.  Heart disease and the inflammatory response , 2000, BMJ : British Medical Journal.

[18]  C. Martínez-A,et al.  The chemokine monocyte chemotactic protein 1 triggers Janus kinase 2 activation and tyrosine phosphorylation of the CCR2B receptor. , 1998, Journal of immunology.

[19]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[20]  J. Berman,et al.  MCP-1/CCL2 protects cardiac myocytes from hypoxia-induced apoptosis by a G(alphai)-independent pathway. , 2005, Biochemical and biophysical research communications.

[21]  B. Rollins,et al.  Chemokines and disease , 2001, Nature Immunology.

[22]  J. Danesh,et al.  Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses , 2000, BMJ : British Medical Journal.

[23]  C A Beltrami,et al.  Structural basis of end-stage failure in ischemic cardiomyopathy in humans. , 1994, Circulation.

[24]  Seung‐Jung Park,et al.  C-Reactive Protein Promotes Monocyte Chemoattractant Protein-1–Mediated Chemotaxis Through Upregulating CC Chemokine Receptor 2 Expression in Human Monocytes , 2004, Circulation.

[25]  B. Cambien,et al.  Signal transduction involved in MCP-1-mediated monocytic transendothelial migration. , 2001, Blood.

[26]  W. Schaper,et al.  Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice mimics ischemic preconditioning through SAPK/JNK1/2 activation. , 2003, Cardiovascular research.

[27]  A. Takeshita,et al.  Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction , 2002, Circulation.

[28]  J. Schaper,et al.  Myocytes Die by Multiple Mechanisms in Failing Human Hearts , 2003, Circulation research.

[29]  I. Charo,et al.  Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis , 1998, Nature.

[30]  U. Ikeda Inflammation and coronary artery disease. , 2003, Current vascular pharmacology.

[31]  J. Badimón,et al.  CCR2 Deficiency Decreases Intimal Hyperplasia After Arterial Injury , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[32]  A. Mastro,et al.  USING TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE (TDT) ENZYME TO DETECT TUNEL-POSITIVE, GFP-EXPRESSING APOPTOTIC CELLS , 2002 .

[33]  L. Becker Yin and yang of MCP-1. , 2005, Circulation research.

[34]  X. Busquets,et al.  IFN-gamma prevents TNF-alpha-induced apoptosis in C2C12 myotubes through down-regulation of TNF-R2 and increased NF-kappaB activity. , 2005, Cellular signalling.

[35]  Luis González-Candelas,et al.  Cloning of a new pectate lyase gene pelC from Fusarium solani f. sp. pisi (Nectria haematococca, mating type VI) and characterization of the gene product expressed in Pichia pastoris. , 1995, Archives of biochemistry and biophysics.

[36]  S. Shirasawa,et al.  Transformation by Oncogenic RAS Sensitizes Human Colon Cells to TRAIL-induced Apoptosis by Up-regulating Death Receptor 4 and Death Receptor 5 through a MEK-dependent Pathway* , 2005, Journal of Biological Chemistry.

[37]  B. Rollins,et al.  Monocyte chemoattractant protein-1. , 1999, Chemical immunology.

[38]  C. Martínez-A,et al.  Monocyte chemoattractant protein-1-induced CCR2B receptor desensitization mediated by the G protein-coupled receptor kinase 2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[39]  S. Shapiro,et al.  Contribution of Monocytes/Macrophages to Compensatory Neovascularization: The Drilling of Metalloelastase-Positive Tunnels in Ischemic Myocardium , 2000, Circulation research.